Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Voillat

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Revue Du Rhumatisme (English Ed.)|July 22, 1998
Anterior chest wall malignancies. A review of ten casesE Toussirot, E Gallinet, B Augé, et al.
British Journal of Haematology|September 1, 1996
The purification of CD34 cells from human cord blood: comparison of separation techniques and cytokine requirements for optimal growth of clonogenic progenitorsP Charbord, I Newton, L Voillat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's diseaseF Maloisel, L Voillat, M P Chenard, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Intra-abdominal localization of acute leukaemia: report of six casesJ E Kurtz, E Andres, F Maloisel, et al.
Bone Marrow Transplantation|January 1, 1991
IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?P Tiberghien, E Racadot, T Fest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaS Limat, K Demesmay, L Voillat, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's diseaseL Voillat, E Deconinck, M Flesch, et al.
Cancer|May 15, 1992
Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect?P Tiberghien, E Racadot, M L Deschaseaux, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Leukemia & Lymphoma|June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphomaG Cartron, L Voillat, B Desablens, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revue Du Rhumatisme (English Ed.)|July 22, 1998
Anterior chest wall malignancies. A review of ten casesE Toussirot, E Gallinet, B Augé, et al.
British Journal of Haematology|September 1, 1996
The purification of CD34 cells from human cord blood: comparison of separation techniques and cytokine requirements for optimal growth of clonogenic progenitorsP Charbord, I Newton, L Voillat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's diseaseF Maloisel, L Voillat, M P Chenard, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Intra-abdominal localization of acute leukaemia: report of six casesJ E Kurtz, E Andres, F Maloisel, et al.
Bone Marrow Transplantation|January 1, 1991
IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?P Tiberghien, E Racadot, T Fest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaS Limat, K Demesmay, L Voillat, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's diseaseL Voillat, E Deconinck, M Flesch, et al.
Cancer|May 15, 1992
Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect?P Tiberghien, E Racadot, M L Deschaseaux, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Leukemia & Lymphoma|June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphomaG Cartron, L Voillat, B Desablens, et al.
Pageof 2